findmyKOL

Michael Weinblatt, MD

Enriched profile

R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology; Co-Director, Clinical Rheumatology, and Associate Director, Center for Arthritis and Joint Diseases, Brigham and Women's Hospital; John and Eileen K. Riedman Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyRheumatologyFocusRheumatoid Arthritis Research and Therapies+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1993–1999

Michael Weinblatt is R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology; Co-Director, Clinical Rheumatology, and Associate Director, Center for Arthritis and Joint Diseases, Brigham and Women's Hospital; John and Eileen K. Riedman Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 533 publications with 54,871 citations (h-index 100); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Michael E. Weinblatt, MD, is R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology at Brigham and Women's Hospital / Harvard Medical School. The public record shows 533 publications with 54,871 citations (h-index 100), centered on Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Spondyloarthritis Studies and Treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 27 companies, 1 NIH-funded awards (1993–1999).

  • Most recent indexed publication: 2026 · BMJ open
  • Top research focus: Rheumatoid Arthritis Research and Therapies
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 27 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Rheumatoid Arthritis1 trialLeukemia (AML/ALL/CML/CLL)Lupus (SLE)Ankylosing Spondylitis / SpA

Research focus

OpenAlex concept fingerprint
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSpondyloarthritis Studies and TreatmentsSystemic Lupus Erythematosus ResearchChronic Lymphocytic Leukemia Research

Drugs & molecules

across trials, industry payments and publications
Reditrexgeneric · MethotrexateClinical trialsIndustry payments1Publications6Hyrimozgeneric · AdalimumabClinical trialsIndustry payments4Publications2Enbrelgeneric · EtanerceptClinical trialsIndustry payments1Publications1

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trialsIndustry payments20E.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments17Abbvie Inc.Clinical trialsIndustry payments15

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
533publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

54,871citations

Total citations across indexed works.

100h-index

Hirsch index (OpenAlex). i10-index 280.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
27companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 1993–1999

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    55.5%
    Folate Analog Metabolic Inhibitor24.4%
    Methotrexate97%Methotrexate Sodium3%
    Part D<11 patients
    TNF inhibitor16.6%
    Humira(Cf) Pen41%Enbrel Sureclick23%Enbrel19%Humira(Cf)10%Cimzia (2 Pack)4%Yuflyma(Cf) (2 Pack)4%
    Part D<11 patients
  • Metabolism & gastrointestinal

    18%
    Corticosteroid15.3%
    Prednisone100%
    Part D73 patients
    Antidiarrheal microorganisms1.6%
    Folic Acid100%
    Part D<11 patients
  • Other

    10.4%
    Folate Analog10.4%
    Leucovorin Calcium100%
    Part D58 patients
5 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)92.7% facility · 7.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 19931999 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

1 congress contribution (2018) across ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Nancy A. Shadick150Christine Iannaccone65Daniel H. Solomon62

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/michael-weinblatt-md-b86824e8

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • Doximity

    doximity.com/pub/michael-weinblatt-md-e0787890

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/michael-weinblatt-09090267

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    rheumnow.live/speakers/view/28

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.live
  • Spotify

    open.spotify.com/show/4Mjzj5jiwUqOzlhEOjKEjN

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • President

    American College of Rheumatology

    2001
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.live
  • Co-Director

    Clinical Rheumatology, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org
  • Associate Director

    Center for Arthritis and Joint Diseases, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
2 more awards behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.